Sort
64,565 grants matching “drug discovery”
Refanalin for lung preservation and transplantation
$957,162Weizhong Cai · Angion Biomedica Corporation · R44 · FY2008 · HL
Experimental Therapeutics of Anti-Cancer Agents with Phase I Emphasis
$957,122Michael R Grever · Ohio State University · UM1 · FY2016 · CA
Metabolic Networks and Pathways in Alzheimer's Disease
$957,041Rima F Kaddurah-Daouk · Duke University · R01 · FY2015 · AG
Translating genomic alterations into novel therapeutic targets in head and neck cancer through computational and functional approaches
$957,000Jeffrey Nicholas Myers · University Of Tx Md Anderson Can Ctr · U01 · FY2016 · DE
Translating genomic alterations into novel therapeutic targets in head and neck cancer through computational and functional approaches
$957,000Jeffrey Nicholas Myers · University Of Tx Md Anderson Can Ctr · U01 · FY2017 · DE
Biostatistics Resource
$956,883Donald A Berry · University Of Tx Md Anderson Can Ctr · P30 · FY2010 · CA
Second Generation Small Molecule Inhibitors of Botulinum Neurotoxins
$956,837Sina Bavari · Geneva Foundation · U01 · FY2011 · AI
RP2: Targeting genes and pathways for autophagy-dependent inhibition of bacterial infection
$956,799Ramnik J Xavier · Ut Southwestern Medical Center · U19 · FY2020 · AI
Agonists of the RIG-I Innate Immune Pathway
$956,404Shawn Patrick Iadonato · Kineta, Inc. · R44 · FY2012 · AI
Center for Genomics and Healthcare Equality
$956,131Wylie G Burke · University Of Washington · P50 · FY2010 · HG
Biophysical mechanisms of gating and modulation in voltage-gated ion channel superfamily
$955,969Baron Chanda · Washington University · R35 · FY2024 · NS
Basic Research Support for the CCR
$955,878Robert Wiltrout · Division Of Basic Sciences - Nci · ZIC · FY2012 · CA
Modeling, pathogenesis and treatment of idiopathic pulmonary fibrosis
$955,428Hans-Willem E Snoeck · Columbia University Health Sciences · U01 · FY2017 · HL
CLINICAL TRIAL PROTOCOLS FOR ACUTE ISCHEMIC STROKE
$955,357Steven Jay Warach · National Institute Of Neurological Disorders And Stroke · ZIA · FY2010 · NS
NOVEL INSIGHTS INTO CEREBRAL ISCHEMIC PATHOPHYSIOLOGY IN HUMANS
$955,357Steven Jay Warach · National Institute Of Neurological Disorders And Stroke · ZIA · FY2010 · NS
Core B: University of Kentucky Alzheimer's Disease Core Center
$955,337Gregory A Jicha · University Of Kentucky · P30 · FY2025 · AG
Multi-site longitudinal Integrated Neurocognitive and Sleep-Behavior Profiler for the Endophenotypic Classification of Dementia Subtypes (INSPECDS)
$955,309Chris Berka · Advanced Brain Monitoring, Inc. · R44 · FY2024 · AG
II. Clinical and Laboratory Studies of the Histone Deacetylase Inhibitor Depsipe
$955,286Susan Bates · Basic Sciences · Z01 · FY2007 · CA
Identification of novel MDR antimicrobials from symbioses between terrestrial and marine invertebrates and rare microbial taxa
$955,138Timothy S Bugni · University Of Wisconsin-Madison · U19 · FY2021 · AI
Proteomic Strategies for AIDS and Drug Abuse - HIV and METH CNS Synergy
$955,065Howard S. Fox · University Of Nebraska Medical Center · P01 · FY2009 · DA
Proteomic Strategies for AIDS and Drug Abuse - HIV and METH CNS Synergy
$954,827Howard S. Fox · University Of Nebraska Medical Center · P01 · FY2008 · DA
Modeling, pathogenesis and treatment of idiopathic pulmonary fibrosis
$954,800Hans-Willem E Snoeck · Columbia University Health Sciences · U01 · FY2016 · HL
Integrative genomic analysis of the human response to glucocorticoids
$954,719Luis Franco · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2024 · AR
Discovery and Translational Services
$954,605Gerald A Beltz · Harvard Medical School · U19 · FY2015 · AI
Second Generation Small Molecule Inhibitors of Botulinum Neurotoxins
$954,452Sina Bavari · Geneva Foundation · U01 · FY2012 · AI